Who We Are
Management Team
Who We Are
Management Team
Jean Chang
Vice President, Clinical Operations
“Working with the Nanoscope team is truly meaningful to me. We're developing gene therapies that have the potential to restore vision for people with severe vision loss—and being part of that journey is both humbling and inspiring. It’s not just about the science; it’s about giving hope to patients and changing lives.”
Jean Chang
Vice President, Clinical Operations
Jean Chang joined Nanoscope Therapeutics in October 2022 as Vice President, Clinical Operations. She brings more than 20 years of experience in clinical operations and project management leading operational conduct of clinical trials through successful submissions in various therapeutic areas including CNS, cardiorenal, hematology, oncology, and ophthalmology. She was a former Executive Director of Clinical Operations at Catalyst Biosciences. She also served as Senior Director, Clinical Operations at Adverum Biotechnologies. Previously Jean held positions with increasing responsibility at Trigemina Inc., Sorbent Therapeutics, MAP Pharmaceuticals and Maxygen. She has vast experience in CRO Management, Global Clinical Trial Management and Clinical Data Management. Jean holds a Bachelor’s degree in Medical Technology from China Medical University in Taiwan and Master’s degree in Immunology from Wayne State University in Michigan.